Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eglandin (Alprostadil) in Living Donor Liver Transplanted Patients
NCT02350218Phase 2Unknown
- Sponsor
- Asan Medical Center
- Start
- Mar 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vasostenoon in liver transplantation, sponsored by Asan Medical Center. Status: unknown.
02
Drugs
Vasostenoon
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT02350218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350218.